Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6619-95-0

Post Buying Request

6619-95-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6619-95-0 Usage

General Description

Deacetylxylopic acid is a chemical compound that belongs to the class of natural products known as lignans, which are found in plants. It is derived from the xylopicalignans, which are a group of lignans that have been isolated from various plant sources. Deacetylxylopic acid has been studied for its potential therapeutic properties, including its antioxidant, anti-inflammatory, and anti-cancer activities. Deacetylxylopic acid has shown promise in preclinical studies for its ability to inhibit the growth of cancer cells, reduce inflammation, and protect cells from oxidative damage. Further research is needed to fully understand the potential benefits and mechanisms of action of deacetylxylopic acid.

Check Digit Verification of cas no

The CAS Registry Mumber 6619-95-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,6,1 and 9 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 6619-95:
(6*6)+(5*6)+(4*1)+(3*9)+(2*9)+(1*5)=120
120 % 10 = 0
So 6619-95-0 is a valid CAS Registry Number.

6619-95-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name (5β,8α,9β,10α,13α,15β)-15-Hydroxykaur-16-en-18-oic acid

1.2 Other means of identification

Product number -
Other names deacetylxylopic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6619-95-0 SDS

6619-95-0Relevant articles and documents

-

Ekong,D.E.U.,Ogan,A.U.

, p. 311 - 312 (1968)

-

Synthesis of a new allelopathic agent from the biotransformation of ent-15α-hydroxy-16-kauren-19-oic acid with Fusarium proliferatum

Rocha,Vieira, H. da S.,Takahashi,Boaventura

, p. 2647 - 2653 (2017)

The use of kaurane diterpenes as substrates in fungal biotransformation to achieve bioactive compounds has been widely reported. In this work, the natural product kaurenoic acid, a diterpene widely distributed in the plant Kingdom, was chemically converted into ent-15α-hydroxy-kaur-16-en-19-oic acid (1). Substrate 1 was subjected to biotransformation by the fungus Fusarium proliferatum, furnishing a new derivative, ent-2α,15α-dihydroxy-kaur-16-en-19-oic acid (2). The structure of metabolite 2 was deduced on the basis of spectroscopy and MS data. Derivative 2 showed allelopathic activity on germination and growth of root and stem of lettuce (Lactuca sativa), inhibiting 100% of germination and growth of roots and stem, at higher concentration assayed (10?4?mol/L).

Ent-Kaurene Glycosides from Ageratina cylindrica

Bustos-Brito, Celia,Sánchez-Castellanos, Mariano,Esquivel, Baldomero,Calderón, José S.,Calzada, Fernando,Yépez-Mulia, Lilian,Joseph-Nathan, Pedro,Cuevas, Gabriel,Quijano, Leovigildo

, p. 2580 - 2587 (2015)

The aqueous extract of the leaves of Ageratina cylindrica afforded six new ent-kaurenoic acid glycosides together with the known diterpenoid paniculoside V, the flavonoid astragalin, chlorogenic acid, and l-chiro-inositol. The structures were elucidated mainly by NMR and MS methods, and the absolute configuration was established by vibrational circular dichroism spectroscopy. The new compounds showed moderate antiprotozoal activity against Entamoeba histolytica and Giardia lamblia trophozoites.

Discovery and structure-activity relationships of ent-Kaurene diterpenoids as potent and selective 11β-HSD1 inhibitors: Potential impact in diabetes

Deng, Xu,Shen, Yu,Yang, Jing,He, Juan,Zhao, Yu,Peng, Li-Yan,Leng, Ying,Zhao, Qin-Shi

, p. 403 - 414 (2013/10/01)

The biological screening of a collection of nature occurring diterpenoids against 11β-HSD1 resulted in the discovery of the lead compound 1b, which pointed to the therapeutic potential for type 2 diabetes. Subsequently, an optimization project was initiated. Starting from compound 1b and its counterpart 2, the hemi-synthesis was performed on kaurenic acid scaffolds yielding 36 derivatives. Further evaluations on both human and mouse 11β-HSD revealed that seven urea derivatives exhibited significant improved potency and selectivity. Especially, the urea 19a has an IC50 (human 11β-HSD1) = 9.4 nM and selectivity index (human 11β-HSD) > 10,649. The 2D and 3D binding models of the complex 19a/11β-HSD1 were generated using docking simulations. Based on the results, the structural-activity relationships (SARs) of compounds 1b and 2 were also discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6619-95-0